
10 Top Studies from The Liver Meeting 2023: At-a-Glance
Simplified risk stratification tools for NAFLD, effects of statins on hepatic disease, trends in OHE, and patient perspectives are samples of the noteworthy research areas.
The Liver Meeting is the annual international scientific gathering sponsored by the American Association for the Study of Liver Disease (AASLD). The 2023 meeting provided breaking news on research across areas including viral hepatitis, metabolic dysfunction-associated steatohepatitis, liver cancer, transplantation, and more.
Of particular note for primary care clinicians were studies on promising, simplified algorithms and risk scores to help effectively stratify patients for specialist referral, the impact of the interplay between hepatic steatosis and level of ASCVD risk on MACE, and hepatoprotection provided by statin drugs. In this quick slide show we offer topline study findings for these and other studies that were conversation topics in Boston, November 10-14, 2023.
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

































































































































































































































































































